Nadesh Ashukem Taku

THU-589-YI Seroprevalence and viral biomarker characterization of hepatitis D infection in treatment naive-infected blood donors with hepatitis B in Cameroon

Rodrigue Kamga Wouambo, Nadesh Ashukem Taku, Noel Simon Ateba, Maria Pfefferkorn et autres

Residual transfusion risk of occult hepatitis B transmission associated to genotypes A and E among blood donors in Yaoundé, Cameroon

Abdou Koudous Bebeto Chouwat, Thibau Flaurant Tchouangueu, Symphorien Ewodo, Nadesh Ashukem Taku et autres

Cameroun, Nigéria (code pays fourni par la source)

Prevalence of prolonged otitis media with effusion among 2 to 3 years old Cameroonian children in the era of 13-valent pneumococcal conjugate vaccines

John Njuma Libwea, Viviane Armelle Ngomba, Nadesh Ashukem Taku, Chanceline Bilounga Ndongo et autres

fi, Cameroun (code pays fourni par la source)

Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011–2018

John Njuma Libwea, Mark A. Fletcher, Paul Koki Ndombo, Angeline Boula et autres

fi, Cameroun, fr, Afrique du Sud, us (code pays fourni par la source)

Seroprevalence of rubella virus antibodies among pregnant women in the Center and South-West regions of Cameroon

Nadesh Ashukem Taku, Valentine Ngum Ndze, Emily Abernathy, Lijuan Hao et autres

Cameroun, us (code pays fourni par la source)

Assessing the causes of under-five mortality and proportion associated with pneumococcal diseases in Cameroon. A case-finding retrospective observational study: 2006–2012

John Njuma Libwea, S. Kingue, Nadesh Ashukem Taku, Marie Kobela et autres

fi, Cameroun (code pays fourni par la source)